Circulating and Local Bone Marrow Renin-angiotensin System in Leukemic Hematopoiesis: Preliminary Evidences

References

• Peart Stanley, W. (1991) "Evolution of renin", Hypertension 18 (Suppl. DI), 100–108.
   Web of Science ®Google Scholar
• Dzau, V.J. (1988) "Tissue renin—angiotensin systems: physio-logic and pharmacological implications", Circulation 77(Suppl. I), 11–13.
   Google Scholar
• Re, R.N. and Bryan, S.E. (1984) "Functional intracellular renin—angiotensin systems may exists in multiple tissues", Hypertens. Clin. Exp. Theory Pract. 6\(Suppl. 10–11), 1739–1742.
   PubMedGoogle Scholar
• Wolny, A., Clozel, J.-P., Rein, J., Mory, P., Vogt, P., Turino, M., Kiowski, W. and Fischli, W. (1997) "Functional and biochemical analysis of angiotensin-II forming pathways in the human heart", Circ. Res. 80, 219–227.
   PubMed Web of Science ®Google Scholar
• Berk, B.C. and Corson, M.A. (1997) "Angiotensin-ll signal transduction in vascular smooth muscle: role of tyrosine kinases", Circ. Res. 80, 607–616.
   PubMed Web of Science ®Google Scholar
• Haznedaroglu, IC., Tuncer, S. and Görsoy, M. (1996) "A local renin—angiotensin system in the bone marrow", Med. Hypotheses 46, 507–510.
   PubMed Web of Science ®Google Scholar
• Wulf, G.G., Streubel, G.J., Nobiling, R., Strutz, F., Hemmer-lein, B., Hiddemarm, W. and Wörmann, B. (1998) "Renin in acute myeloid leukaemia blasts", Br. J. Haematol. 100, 335–337.
   PubMed Web of Science ®Google Scholar
• Hajek, D., Kubesova, H., Vyzula, R., Mayer, J., Druckmueller, M., Tomiska, M. and Vasku, A. (1999) "Bone marrow as multidimensional orbit oscillator after autologous bone marrow transplantation", Stem Cells 17, 25–30.
   PubMed Web of Science ®Google Scholar
• Rousseau-Plasse, A., Wdzieczak-Bakala, J., Lenfant, M., Ezan, E., Genet, R., Robinson, S., Bricoe, T., Melville, J. and Riches, A. (1998) "Lisinopril, an angiotensin-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo", Exp. Hematol. 26, 1074–1079.
   PubMed Web of Science ®Google Scholar
• Rieger, K., Saez-Servent, N., Papet, ME, Wdzieczak-Bakala, J., Morgat, J.L., Thierry, J., Voelter, W. and Lenfant, M. (1993) "Involvement of human plasma angiotensin-I-converting enzyme in degradation of the hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro", Biochem. J. 296, 373–378.
   PubMed Web of Science ®Google Scholar
• Rousseau, A., Michaud, A., Chauvet, M.T., Lenfant, M. and Corvol, P. (1993) "The hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate for the N-terminal active site of human angiotensin-I converting enzyme", J. Biol. Chem. 270, 3656–3661.
   Web of Science ®Google Scholar
• Azizi, M., Rousseau, A., Ezan, E., Guyene, T.T., Michelet, S., Grognet, J.M., Lenfant, M., Corvol, P. and Menard, J. (1996) "Acute angiotensin converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (AcSDKP)", J. Clin. Investig. 97, 839–844.
   PubMed Web of Science ®Google Scholar
• Mrug, M., Stopka, T., Julian, B.A. and Prchal, J.F. (1997) "Angiotensin-ll stimulates proliferation of normal early erythroid progenitors", J. Clin. Investig. 100, 2310–2314.
   PubMed Web of Science ®Google Scholar
• Marrero, M.B., Schieffer, B., Paxton, W.G., Heerdt, L., Berk, B.C., Delafontaine, P. and Bernstein, K.E. (1995) "Direct stimulation of JAK-STAT pathway by the angiotensin-ll AT1 receptor", Nature 375, 247–250.
   PubMed Web of Science ®Google Scholar
• Rodgers, K.E., Xiong, S., Steer, R. and DiZerega, GS. (2000) "Effect of angiotensin-ll on hematopoietic progenitor cell proliferation", Stem Cells 18, 287–294.
   PubMed Web of Science ®Google Scholar
• Holmquist, B., Bunning, P. and Riordan, J.F. (1979) "A continous spectrophotometric assay for angiotensin convert-ing enzyme", Anal. Biochem. 95, 540–544.
   PubMed Web of Science ®Google Scholar
• Miles, L.E. (1975) "Properties, variants, and applications of the immunoradiometric assay method", Ric. Clin. Lab. 5, 59–72.
   PubMedGoogle Scholar
• Haznedaroglu, IC. (1998) "A local renin angiotensin system in the bone marrow still awaits its Christopher Columbus", Exp. Hematol. 26, 279.
   Web of Science ®Google Scholar
• Haznedaroglu, IC. and Bilyökasik, Y. (1997) "Current evidence for the existence of a local renin—angiotensin system affecting physiologic and pathologic haemopoiesis in the bone marrow", Br. J. Haematol. 99, 471.
   PubMed Web of Science ®Google Scholar
• Wulf, G., Jahns-Streubel, G., Strutz, F., Basenau, D., Huffier, M., Buske, C., Wormann, B. and Hiddemarm, W. (1996) "Paraneoplastic hypokaelemia in acute myeloid leukemia: a case of renin activity in AML blast cells", Ann. Hematol. 73, 139–141.
   PubMed Web of Science ®Google Scholar
• Dostal, D.E. and Baker, K.M. (1999) "The cardiac renin—angiotensin system: conceptual, or a regulator of cardiac function?", Circ. Res. 85, 643–650.
   PubMed Web of Science ®Google Scholar
• Masse, A., Ramirez, L.H. and Bindoula, G. (1993) "The tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects from doxorubicin induced toxicity: improvement in mice survival and protection of bone marrow stem cells and progenitors", Blood 91, 441–444.
   Google Scholar
• Guigon, M., Bonet, D., Lemoine, F., Kobari, L., Parmentier, C., Mary, J.Y. and Najman, A. (1990) "Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP", Exp. Hematol. 18, 1112–1115.
   PubMed Web of Science ®Google Scholar
• Robinson, S., Lenfant, M., Wdzieczak-Bakala, J., Melville, J. and Riches, A. (1992) "The mechanism of action of tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation", Cell Prolif. 25, 623–632.
   PubMed Web of Science ®Google Scholar
• Nomura, S., Sugihara, T., Tomiyama, T., Kitano, Y., Yawata, Y. and Osawa, G. (1996) "Polycythaemia vera: response to treatment with angiotensin converting enzyme inhibitor", Fur. J. Haematol. 57, 117–119.
   PubMed Web of Science ®Google Scholar
• Heim, M.H. (1996) "The JAK-STAT pathway: specific signal transduction from the cell membrane and the nucleus", Fur. J. Clin. Invest. 26, 1–12.
   Web of Science ®Google Scholar
• Ihle, J.N. and Kerr, I.M. (1995) "JAKs and STATs in signalling by cytoldne receptor superfamily", Trends Genet. 11, 69–73.
   PubMed Web of Science ®Google Scholar
• Richard, M. and Ransohof, M.D. (1998) "Cellular responses to interferons and other cytokines: the JAK-STAT Paradigm", N. Engl. J. Med. 338, 606–608.
   Web of Science ®Google Scholar
• Haznedaroglu, IC., Arici, M. and Böyökasik, Y. (2000) "A unifying hypothesis for renin—angiotensin system and hematopoiesis: sticking the pieces with JAK-STAT pathway", Med. Hypotheses 54, 80–83.
   PubMed Web of Science ®Google Scholar
• Crabos, M., Bertschin, S., Böhler, ER., Rogg, H., Evequoz, D., Eberhard, M. and Erne, P. (1993) "Identification of AT1 receptors on human platelets and decreased angiotensin-ll binding in hypertension", J. Hypertens. 11\(Suppl. 5 , 230–231.
   Google Scholar
• Larsson, PT., Schwieler, J.H. and Waller', N.H. (2000) "Platelet activation during angiotensin II infusion in healthy volun-teers", Blood Coagul. Fibrinolysis 11, 61–69.
   PubMed Web of Science ®Google Scholar
• Larsson, PT., Schwieler, J.H., Wallen, N.H. and Hjemdahl, P. (1999) "Acute effects of angiotensin II on fibrinolysis in healthy volunteers", Blood Coagul. Fibrinolysis 10, 19–24.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega, M., Lorenzo, O., Ruperez, M. and Egido, J. (2000) "ACE inhibitors and AT1 receptor antagonists-beyond the hemodynamic effect", Nephrol. Dial. Transplant. 15, 561–565.
   PubMed Web of Science ®Google Scholar
• Gaudrone, S., Grillon, C., Thierry, J., Riches, A., Wierenga, P.K. and Wdzieczak-Bakala, J. (1999) "In vitro effect of Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) Analogs resistant to angioten-sin I-converting enzyme on hematopoietic stem cell and progenitor cell proliferation", Stem Cells 17, 100–106.
   PubMed Web of Science ®Google Scholar